|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Cardiovascular Medicine, Bispebjerg University Hospital, Copenhagen, Denmark
2 Department of Medical Physiology, University of Copenhagen, Copenhagen, Denmark
3 Department of Cardiovascular Medicine, Frederiksberg University Hospital, Copenhagen, Denmark
4 Department of Medical Endocrinology, Herlev University Hospital, Copenhagen, Denmark
5 Department of Physiology and Pharmacology, University of Southern Denmark, Odense, Denmark
6 Department of Clinical Physiology and Nuclear Medicine, Bispebjerg University Hospital, Copenhagen, Denmark
* To whom correspondence should be addressed. E-mail: mdamgaard{at}dadlnet.dk.
Patients with untreated heart failure exhibit a blunted hemodynamic and neuroendocrine response to a high sodium intake leading to excessive sodium and water retention. It is, however, not known whether this is the case for patients with compensated HF receiving ACE-inhibitors and
-adrenoreceptor blockers. Therefore we determined the hemodynamic and neuroendocrine response to one week of a low sodium diet (70 mmol/day) and one week of a high sodium diet (250 mmol/day) in 12 HF patients and 12 age-matched controls in a randomized balanced fashion. During steady state conditions, hemodynamic and neuroendocrine examinations were performed at rest and during bicycle exercise. In seated HF patients, high sodium intake increased body weight (1.6 ± 0.4%), plasma volume (9 ± 2%), cardiac index (14 ± 6%), and stroke volume index (21 ± 5%) whereas mean arterial pressure was unchanged. Therefore, the total peripheral resistance decreased by 10 ± 4%. Similar hemodynamic changes were observed during an incremental bicycle exercise test. Plasma concentrations of angiotensin II and norepinephrine were suppressed whereas plasma pro-B-type natriuretic peptide remained unchanged. In conlusion, high sodium intake was tolerated without any excessive sodium and water retention in medically treated patients with compensated HF. The observation that high sodium intake improves cardiac performance, induces peripheral vasodilatation, and suppresses the release of vasoconstrictor hormones does not support the advice for HF patients to restrict dietary sodium.
This article has been cited by other articles:
![]() |
K. R. Beich and C. Yancy The Heart Failure and Sodium Restriction Controversy: Challenging Conventional Practice Nutr Clin Pract, October 1, 2008; 23(5): 477 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kjolby and P. Bie Chronic activation of plasma renin is log-linearly related to dietary sodium and eliminates natriuresis in response to a pulse change in total body sodium Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R17 - R25. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Damgaard, J. P. Goetze, P. Norsk, and N. Gadsboll Altered sodium intake affects plasma concentrations of BNP but not proBNP in healthy individuals and patients with compensated heart failure Eur. Heart J., November 2, 2007; 28(22): 2726 - 2731. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ivarsen, J. V. Povlsen, and J. D. Jensen Increasing fill volume reduces cardiac performance in peritoneal dialysis Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2999 - 3004. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |